Ruxolitinib Prior to Transplant in Patients With Myelofibrosis

Clinical trial NCT01790295 · TERMINATED

Trial details

NCT number: NCT01790295
Sponsor: John Mascarenhas
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Post Polycythemia Vera Myelofibrosis Post Essential Thrombocythemia Myelofibrosis

Start date: 2013-11-01
Primary completion: 2017-10-26
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.